| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.22 | 0.4 |